Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Menu
Advanced
Wish Lists Wish Lists
Wish Lists Wish Lists
Wish Lists
Cart Cart
Cart Cart
Cart
Sign in
Sign in
Contact us
Advanced
Homepage > Company > Media > Pharma News > 2015

Pharma News, 2015

FDA Approves Basaglar® (insulin glargine injection), a Long-Acting Insulin Treatment
FDA Approves Basaglar® (insulin glargine injection), a Long-Acting Insulin Treatment
INDIANAPOLIS and RIDGEFIELD, Conn.
Nurofen maker Reckitt Benckiser defends Australia packaging
Nurofen maker Reckitt Benckiser defends Australia packaging
The UK maker of the Nurofen "specific pain" range of products has defended their packaging, after an Australian court ordered the products off shelves.
FDA Approves Bridion (sugammadex) to Reverse Effects of Neuromuscular Blocking Drugs
FDA Approves Bridion (sugammadex) to Reverse Effects of Neuromuscular Blocking Drugs
December 15, 2015 -- The U.
Scientists identify a molecular key that helps maintain identity and prevents the conversion of adult cells into iPS cells
Scientists identify a molecular key that helps maintain identity and prevents the conversion of adult cells into iPS cells
By Hannah L.
Novo Nordisk Files for Regulatory Approval of Faster-Acting Insulin Aspart in the US for the Treatment of Type 1 and 2 Diabetes
Novo Nordisk Files for Regulatory Approval of Faster-Acting Insulin Aspart in the US for the Treatment of Type 1 and 2 Diabetes
Novo Nordisk  announced the submission of the New Drug Application (NDA) for faster-acting insulin aspart to the US Food and Drug Administration (FDA).
Pharmaceutical research firm PPD explores sale, IPO: Reuters
Pharmaceutical research firm PPD explores sale, IPO: Reuters
(Reuters) — Contract research organization Pharmaceutical Product Development LLC (PPD) is exploring a sale or initial public offering that could value it at between $7 billion and $...
Mylan wants some payback for plants it bought from Strides cited by FDA
Mylan wants some payback for plants it bought from Strides cited by FDA
Tuesday, December 15, 2015 | By Eric Palmer.
Drug approvals top 2014 high but R&D returns still struggle
Drug approvals top 2014 high but R&D returns still struggle
The number of new drugs approved in the United States this year has already topped last year's 18-year high, yet large pharmaceutical companies are still struggling to get a decent return on their...
AstraZeneca in talks with Dutch cancer drugs firm Acerta Pharma
AstraZeneca in talks with Dutch cancer drugs firm Acerta Pharma
British phamaceuticals giant AstraZeneca is in discussions with cancer drug maker Acerta Pharma over a potential deal.
Wellstat Announces FDA Approval of VISTOGARD® (Uridine Triacetate), the First Antidote to Treat Overdoses and Early-Onset Severe Toxicities Due to 5-Fluorouracil (5-FU) and Capecitabine Chemotherapies
Wellstat Announces FDA Approval of VISTOGARD® (Uridine Triacetate), the First Antidote to Treat Overdoses and Early-Onset Severe Toxicities Due to 5-Fluorouracil (5-FU) and Capecitabine Chemotherapies
GAITHERSBURG, Md.
Pesticide Found In Milk Decades Ago Linked To Parkinson's
Pesticide Found In Milk Decades Ago Linked To Parkinson's
TOKYO.
FDA Grants Genentech's Alecensa® (Alectinib) Accelerated Approval For People With A Specific Type Of Lung Cancer
FDA Grants Genentech's Alecensa® (Alectinib) Accelerated Approval For People With A Specific Type Of Lung Cancer
Genentech, a member of the Roche Group (SIX.
0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Custom chemistry. Chemistry FTE. Resynthesis.
Hit Follow up Support
Medicinal chemistry FTE
In silico drug design (CADD)
Discovery Biology. Biology FTE. In vitro studies.
Animal models
Toxicology and safety
ADME, DMPK. In vivo studies
Chemistry, manufacturing and controls
Company
News & Media
Contact us
Trends in discovery compounds